Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.
about
Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's DiseaseCurrent approaches to enhance glutamate transporter function and expressionExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsChoreoathetosis Is a Possible Adverse Event of a Commonly Used AntibioticExercise-Mediated Increase in Nigral Tyrosine Hydroxylase Is Accompanied by Increased Nigral GFR-α1 and EAAC1 Expression in Aging RatsRegulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.Axial levodopa-induced dyskinesias and neuronal activity in the dorsal striatum.Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat.Native DIGE proteomic analysis of mitochondria from substantia nigra and striatum during neuronal degeneration and its compensation in an animal model of early Parkinson's disease.Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model.Ceftriaxone Protects Astrocytes from MPP(+) via Suppression of NF-κB/JNK/c-Jun Signaling.
P2860
Q26765084-5E7CF6E3-989E-4BBA-BD5A-88C6BD8EF98DQ26996723-648B5FC7-E7E0-4B22-B18A-A97DF5DBE5E1Q28075692-B86674F2-2E01-415A-A6D3-66BA68F1179FQ33706000-FB0E8749-1BB5-47A1-A45B-EC5DBF613AD5Q37051146-6C6F262D-07C6-4E00-9CA0-1267DC53C195Q37116151-C65FEBC2-EF34-4D79-A7ED-EBB3692C8A9FQ38512084-D8F83B0B-AF14-48BA-A233-3B26FFF39DC6Q38932223-97DD31C3-24AA-466D-8F0B-5839B526C3A1Q39107780-1253F16B-5D81-4772-8A69-CE7225C3690FQ41817045-DFBAC928-AE17-452D-AF37-1FBB0FB01257Q48598969-00F7602F-66EB-4F96-8A35-395CB47430E7Q48631361-36E4BAB6-9EBC-49C3-928D-9D945C483C2EQ55071924-67F31257-6C40-4F59-8E12-2E5CD0F1C53B
P2860
Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Ceftriaxone increases glutamat ...... s in 6-OHDA Parkinson's model.
@en
type
label
Ceftriaxone increases glutamat ...... s in 6-OHDA Parkinson's model.
@en
prefLabel
Ceftriaxone increases glutamat ...... s in 6-OHDA Parkinson's model.
@en
P2093
P2860
P1476
Ceftriaxone increases glutamat ...... s in 6-OHDA Parkinson's model.
@en
P2093
James W Geddes
Jennifer C Arnold
Michael F Salvatore
Richard W Davis
Shawn Gurwara
Tanya Chotibut
Vimala Bondada
Zachary Frenchek
P2860
P2888
P304
P356
10.1007/S12035-013-8598-0
P577
2013-12-03T00:00:00Z
P5875
P6179
1039024548